Published in:
Open Access
01-12-2014 | Meeting abstract
EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine
Authors:
C Schankin, F Maniyar, Y Seo, S Kori, M Eller, J Blecha, S Murphy, T Sprenger, H VanBrocklin, P Goadsby
Published in:
The Journal of Headache and Pain
|
Special Issue 1/2014
Login to get access
Excerpt
Due to unfavorable molecular size and lipophilicity, migraine-specific medications such as dihydroergotamine (DHE) are not expected to penetrate the blood-brain barrier (BBB). A breakdown of the BBB during migraine attacks has been postulated as the mechanism in which DHE accesses postulated central sites of action. …